Literature DB >> 37877

beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.

N K Hollenberg, D F Adams, D N McKinstry, G H Williams, L J Borucki, J M Sullivan.   

Abstract

1 Nadolol was administered intravenously to five hypertensive patients and three healthy volunteers in balance on a 10 mEq sodium intake. 2 Nadolol (0.3-10.0 micrograms/kg) induced a significant, dose-related increase in renal blood flow, measured with radioxenon, with a maximum increase of 72 +/- 4 ml/100g/min (26%) at 3.0 micrograms/kg. 3 Heart rate and plasma renin activity decreased significantly over the same dose range. 4 The renal vascular response to nadolol contrasts sharply with those found with other beta-adrenoceptor-blocking agents. 5 The magnitude of the increase in renal blood flow, its time-course and the parallel fall in plasma renin activity raise the possibility that the renal vasodilation reflects the reversal of angiotensin's influence on the renal arterial bed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37877      PMCID: PMC1429339          DOI: 10.1111/j.1365-2125.1979.tb04693.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  Acute effects of tolamolol on renal function in hypertensive patients.

Authors:  C Bianchi; M Bonadio; C Donadio; G Tramonti; S Figus; P Papalexiou
Journal:  Experientia       Date:  1976-12-15

2.  Effect of some beta-adrenergic blocking drugs on the renal bloow flow in dogs.

Authors:  M Abdel-Razzak
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-10

3.  The use of frusemide and propranool in the treatment of the hypertension of chronic renal disease.

Authors:  R Wilkinson; M Pickering; V Robson; R W Elliott; D N Kerr
Journal:  Scott Med J       Date:  1974       Impact factor: 0.729

4.  Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma.

Authors:  R L Emanuel; J P Cain; G H Williams
Journal:  J Lab Clin Med       Date:  1973-04

5.  Unwanted effects of propranolol.

Authors:  S A Stephen
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

6.  The presence of beta-adrenergic receptors in the renal vascular bed.

Authors:  T Fenyvesi; K Kállay
Journal:  Acta Physiol Acad Sci Hung       Date:  1970

7.  Evidence of renal hemodynamic changes encountered after dichloroisoproterenol.

Authors:  N Cooper; W F Barry; P Labay; S Boyarsky
Journal:  Invest Urol       Date:  1967-01

8.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.

Authors:  H Ibsen; P Sederberg-Olsen
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

9.  Letter: Beta-blockade in the presence of renal disease and hypertension.

Authors:  F D Thompson; A M Joekes
Journal:  Br Med J       Date:  1974-06-08

Review 10.  Renal vascular tone in essential and secondary hypertension: hemodynamic and angiographic responses to vasodilators.

Authors:  N K Hollenberg; D F Adams; H Solomon; W R Chenitz; B M Burger; H L Abrams; J P Merrill
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

View more
  17 in total

1.  Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.

Authors:  T Baba; S Murabayashi; K Aoyagi; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Dose proportionality of nadolol pharmacokinetics after intravenous administration to healthy subjects.

Authors:  R A Morrison; S M Singhvi; W A Creasey; D A Willard
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Renal effects of nadolol in cirrhosis.

Authors:  A Gatta; D Sacerdoti; C Merkel; L Caregaro; M Borsato; M Bolognesi; A Ruol
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Beta-blockers and renal function.

Authors:  R Wilkinson
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

Review 5.  [The influence of beta-receptor blockers on metabolism (author's transl)].

Authors:  F W Lohmann
Journal:  Klin Wochenschr       Date:  1981-01-15

Review 6.  Systemic and regional haemodynamic profile of diuretics and alpha- and beta-blockers. A review comparing acute and chronic effects.

Authors:  A Mimran; G Ducailar
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent.

Authors:  Z Glück; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.

Authors:  I G Mackay; A M Macnicol; H J Smith; A D Cumming; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

9.  Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.

Authors:  A G Dupont; P Vanderniepen; A M Bossuyt; M H Jonckheer; R O Six
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

Review 10.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.